EU plans first-ever evaluation of health impacts of e-cigarettes and nicotine products in tobacco directive revision

Sep.22.2025
EU plans first-ever evaluation of health impacts of e-cigarettes and nicotine products in tobacco directive revision
EU to assess health impact of e-cigarettes and nicotine-containing products for the first time during tobacco directive revision.

Key Points:

 

·Assessment Action: The European Union is planning to assess the health impacts of nicotine-containing products such as e-cigarettes for the first time when revising the Tobacco Products Directive. The assessment will be based on EU-funded research and WHO anti-tobacco principles, with specific methods yet to be determined. 

·Multiple Perspectives: The tobacco industry claims that new products are less harmful than traditional cigarettes and supports third-party independent research. However, the WHO, the EU, and health experts believe that these products are harmful, potentially affecting young people, and advocate for taxation. Health and anti-cancer organizations are calling for regulation of alternative tobacco products. 

·Industry Relations: Tensions between the tobacco industry and the European Commission have escalated due to the EU's proposal to increase tobacco product taxes and include some tobacco tax revenue in future budgets. 

·Taxation Plan: The EU plans to increase taxes on cigarettes and new tobacco products, aiming to include 15% of tobacco tax revenue in the EU budget for 2028-2034.

 


 

In a groundbreaking move, the European Commission plans to assess the impact of e-cigarettes, heated tobacco, and other nicotine-containing products on health for the first time during the revision of the major tobacco directive in 2025, as reported by Euractiv on September 19th. An official from the European Commission revealed that this assessment will be solely based on research funded by the European Fund and will adhere to the anti-tobacco guidance principles outlined by the World Health Organization Framework Convention.

 

The President of Philip Morris International (PMI) Europe, Massimo Andolina, stated that the group "fully supports in-depth research conducted by independent third-party scientific organizations to validate our claims," but he did not specify which organizations meet this standard.

 

Currently, it is unclear how exactly the European Commission will conduct this assessment. The tobacco industry claims that new products are less harmful than traditional cigarettes, but the World Health Organization and the European Union believe that these products are still harmful to health and could potentially serve as a gateway for youth smoking.

 

Several health and anti-cancer organizations have recently sent letters to European Union member states urging action on alternative tobacco products, arguing that these products pose an "increasingly serious threat" to public health and "encourage" young people to start using nicotine.

 

At the same time, tensions between the tobacco industry and the European Commission have escalated, with the latter recently proposing an increase in taxes on both cigarettes and new tobacco products. Additionally, Brussels is also planning to include 15% of tobacco tax revenue in the EU's next budget cycle (2028-2034).

 

European Union Health Commissioner Olivér Várhelyi pointed out that products like e-cigarettes are extremely popular among young people and pose significant health risks. He stated, "These products are not yet taxed, and I am clearly in favor of them being taxed.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

China Discloses First Criminal Case Over Counterfeit Vapes Disguised as “Medical Nebulizers” and “Zero-Nicotine” Products
China Discloses First Criminal Case Over Counterfeit Vapes Disguised as “Medical Nebulizers” and “Zero-Nicotine” Products
Chinese authorities have disclosed the country’s first reported criminal case involving counterfeit vapes marketed as “medical nebulizers” and “zero-nicotine” products. Authorities determined that the products involved were counterfeit vapes and pursued criminal charges for producing and selling counterfeit goods. According to the report, the case resulted in the seizure of 347,000 counterfeit vape pods and 53,700 vape devices, with physical goods valued at 22.13 million yuan.
Aug.04
HG Innovation, linked to IMiracle and ELFBAR, wins China patent for 6-methylnicotine salts covering vaping and oral products
HG Innovation, linked to IMiracle and ELFBAR, wins China patent for 6-methylnicotine salts covering vaping and oral products
HG Innovation Limited has been granted a Chinese invention patent covering 6-methylnicotine salt formulations and their use in oral and vaping products. The technology forms salts between 6-methylnicotine and alicyclic carboxylic acids, with granted claims extending to oral products, atomization substrates and electronic atomization devices. Applicant-generated tests reported differences in oxidation stability, in-vitro cytotoxicity and aerosol heavy-metal performance compared with selected benzoate or lactate controls. HG Innovation is directly linked to the broader IMiracle and ELFBAR business network.
Sep.04
 $20 Million, a Permanent Injunction and Distributor Controls: Posh Deal Tightens Illinois Vape Compliance
$20 Million, a Permanent Injunction and Distributor Controls: Posh Deal Tightens Illinois Vape Compliance
An Illinois court ordered three companies tied to Posh vapes to pay $20 million and permanently restricted the sale, marketing and distribution in Illinois of products lacking required FDA authorization. The consent order also imposes downstream distributor controls, age-verification measures and social-media marketing limits, creating a new state-level compliance benchmark for disposable vape businesses.
Regulations
Aug.05
InterTabac 2026: Further Sessions on Regulation, Market Access and Innovation Confirmed; 2FIRSTS to Host China Market Forum
InterTabac 2026: Further Sessions on Regulation, Market Access and Innovation Confirmed; 2FIRSTS to Host China Market Forum
InterTabac 2026 will bring together international experts to discuss European regulation, tax policy, Track & Trace, market access, retail impacts, consumer behavior and innovation. Sessions will also examine Poland’s tobacco-growing perspective and the growing fragmentation of Europe’s tobacco and nicotine market. Media partner 2FIRSTS will host the second “2FIRSTS Connect at InterTabac” on September 16, focusing on developments in China’s tobacco and nicotine industry.
Aug.06
China’s Jinhua Tobacco Launches CNY 2.7 Million Procurement for E-Cigarette Violation Lead Monitoring Services
China’s Jinhua Tobacco Launches CNY 2.7 Million Procurement for E-Cigarette Violation Lead Monitoring Services
Jinhua Tobacco, a municipal tobacco company in China’s Zhejiang province, has launched a public tender for e-cigarette-related violation lead monitoring and consulting services. The project is valued at CNY 2.7 million and covers data resource integration and analytical consulting services for 36 months from contract signing. The procurement reflects the use of external data and analysis services to support local tobacco companies’ market oversight activities related to e-cigarettes.
Aug.07
Australia-China Operation Dismantles Tobacco Smuggling Network: 112 Containers, 60 Arrests and A$92 Million in Illicit Tobacco
Australia-China Operation Dismantles Tobacco Smuggling Network: 112 Containers, 60 Arrests and A$92 Million in Illicit Tobacco
According to The Maritime Executive on August 19, 2026, the Australian Border Force (ABF) and China’s Anti-Smuggling Bureau of General Administration of China Customs worked together to dismantle an international illicit tobacco smuggling network targeting Australia. According to information released by ABF on August 20, sustained information sharing and cooperation led to investigations into 112 shipping containers, with 91 found to contain illicit tobacco. Authorities seized more than 60 million cigarettes and 60 kilograms of loose-leaf tobacco, representing more than A$92 million in unpaid duties. More than 60 people suspected of involvement in the network were arrested in China.
Aug.20